SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028043
Filing Date
2016-11-08
Accepted
2016-11-07 18:58:24
Documents
45
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20160930.htm 10-Q 1687982
2 EX-31.1 rare-ex311_6.htm EX-31.1 17414
3 EX-31.2 rare-ex312_9.htm EX-31.2 17492
4 EX-32.1 rare-ex321_11.htm EX-32.1 10811
5 GRAPHIC g2016110723475990211431.jpg GRAPHIC 50503
  Complete submission text file 0001564590-16-028043.txt   4429686

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rare-20160930.xml EX-101.INS 810744
7 XBRL TAXONOMY EXTENSION SCHEMA rare-20160930.xsd EX-101.SCH 27820
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20160930_cal.xml EX-101.CAL 34170
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20160930_def.xml EX-101.DEF 74023
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20160930_lab.xml EX-101.LAB 208547
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20160930_pre.xml EX-101.PRE 150546
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 161979571
SIC: 2834 Pharmaceutical Preparations